NOG 抗体 (AA 156-170)
Quick Overview for NOG 抗体 (AA 156-170) (ABIN1737419)
抗原
See all NOG 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 156-170
-
特异性
- Reacts with Noggin from human, mouse and rat
-
纯化方法
- Antigen affinity purified
-
免疫原
- Synthetic peptide comprising residues 156-170 [PVLYAWNDLGSRFWP] of the human Noggin protein
-
亚型
- IgG
-
-
anti-Noggin (NOG) (AA 28-232) antibody
NOG 适用: 人, 犬 WB, IHC, IF, IHC (p) 宿主: 小鼠 Monoclonal 4C12 unconjugated
anti-Noggin (NOG) (AA 28-232) antibodyNOG 适用: 人 WB, IHC 宿主: 小鼠 Monoclonal A7 unconjugated
anti-Noggin (NOG) (AA 28-232) antibodyNOG 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Noggin (NOG) (AA 1-232) antibodyNOG 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Noggin (NOG) (AA 28-130) antibodyNOG 适用: 小鼠, 大鼠 WB, ELISA, FACS, IF (cc), IF (p), IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Noggin (NOG) (AA 28-232) antibodyNOG 适用: 人 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Noggin (NOG) antibodyNOG 适用: 人, 小鼠 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Noggin (NOG) (AA 21-70) antibodyNOG 适用: 人 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Noggin (NOG) (AA 28-232) antibodyNOG 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 4C9 unconjugated
anti-Noggin (NOG) (AA 1-232) antibodyNOG 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
-
-
应用备注
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
- WB : 1/1 000 to 1/2 000 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS, Sodium azide 0.02 %
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
有效期
- 6 months
-
-
- NOG (Noggin (NOG))
-
别名
- Noggin
-
背景
- Noggin is involved in numerous developmental processes, such as neural tube fusion and joint formation. The morphogenesis of organs is initiated by a downgrowth from a layer of epithelial stem cells. This process is achieved through the receipt of signals from 1) a WNT protein (WNT3A) to stabilize beta-catenin, and 2) Noggin, which is a bone morphogenetic protein inhibitor.Noggin mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) have been identified, which have multiple joint fusion as their principal defect.
-
途径
- Stem Cell Maintenance, Tube Formation
抗原
-
